Evidence map›Paper›PMID 36630954›Full record

ArticleMolecular cell2023

Human SMARCA5 is continuously required to maintain nucleosome spacing.

Monica L Bomber, Jing Wang, Qi Liu, Kelly R Barnett, Hillary M Layden, Emily Hodges, Kristy R Stengel, Scott W Hiebert

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. SMARCA5 restricts chromatin accessibility to promote male meiosis and fertility in mammals.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Monica L BomberDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Jing WangDepartment of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37203, USA; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Qi LiuDepartment of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37203, USA; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Kelly R BarnettDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Hillary M LaydenDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Emily HodgesDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Kristy R StengelDepartment of Cell Biology, Albert Einstein College of Medicine, New York, NY, USA. Electronic address: kristy.stengel@einsteinmed.edu.
Scott W HiebertDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Electronic address: scott.hiebert@vanderbilt.edu.
Vanderbilt University · USAlbert Einstein College of Medicine · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
BIOCHEMICAL &CHEMICAL TRAINING FOR CANCER RESEARCHT32CA009582 · NCI · VANDERBILT UNIVERSITY · PI David K Cortez · 1987 to 2026
$8.8M
Hdac3 as a therapeutic target in BCL6-dependent lymphomaR01CA164605 · NCI · VANDERBILT UNIVERSITY · PI HIEBERT, SCOTT W · 2012 to 2022
$3.9M
Role of PRC1 in RUNX1-ETO-mediated transcriptional controlR01CA255446 · NCI · VANDERBILT UNIVERSITY · PI HODGES, EMILY · 2021 to 2025
$2.1M
CRISPR-mediated Chemical Genetics Define Transcription Factor Gene Networks and Mechanisms of ControlR35GM147213 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Kristy Stengel · 2022 to 2026
$2.1M
The role of MTG8 in transcriptional elongation and leukemiaF32CA174162 · NCI · VANDERBILT UNIVERSITY · PI STENGEL, KRISTY · 2013 to 2013
$21k
NCATS NIH HHS UL1 TR000445NCI NIH HHS F32 CA174162NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA164605NCI NIH HHS R01 CA255446NCI NIH HHS T32 CA009582NCRR NIH HHS UL1 RR024975NIDDK NIH HHS P30 DK058404NIGMS NIH HHS R35 GM147213
6 · The paper itself

Abstract

Genetic models suggested that SMARCA5 was required for DNA-templated events including transcription, DNA replication, and DNA repair. We engineered a degron tag into the endogenous alleles of SMARCA5, a catalytic component of the imitation switch complexes in three different human cell lines to define the effects of rapid degradation of this key regulator. Degradation of SMARCA5 was associated with a rapid increase in global nucleosome repeat length, which may allow greater chromatin compaction. However, there were few changes in nascent transcription within the first 6 h of degradation. Nevertheless, we demonstrated a requirement for SMARCA5 to control nucleosome repeat length at G

Indexed as

ChromatinChromosomal Proteins, Non-HistoneDNA RepairNucleosomesAdenosine TriphosphatasesCell LineHistonesHumansAdenosine TriphosphatasesChromatinChromosomal Proteins, Non-HistoneHistonesNucleosomesSMARCA5 protein, humanATAC-seqchromatinCTCFH2A.ZMNase-seqnucleosome repeat lengthPRO-seqSMARCA5

Identifiers

PMID36630954
PMCPMC9974918
OpenAlexW4315475845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.